Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B Porter

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Hematology/Oncology Clinics of North America|July 28, 2014
The pathophysiology of transfusional iron overloadJohn B Porter, Maciej Garbowski
Hematology/Oncology Clinics of North America|February 21, 2018
Interaction of Transfusion and Iron Chelation in ThalassemiasJohn B Porter, Maciej W Garbowski
Best Practice & Research. Clinical Haematology|October 29, 2002
Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemiaJohn B Porter, Bernard A Davis
Advances in Experimental Medicine and Biology|February 8, 2003
Results of long term iron chelation treatment with deferoxamineBernard A Davis, John B Porter
Hematology/Oncology Clinics of North America|November 16, 2010
Iron overload in thalassemia and related conditions: therapeutic goals and assessment of response to chelation therapiesJohn B Porter, Farrukh T Shah
Hemoglobin|June 8, 2010
Which psychosocial factors are related to chelation adherence in thalassemia? A systematic reviewMichael Evangeli, Kulsoom Mughal, John B Porter
Blood|October 24, 2007
Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia majorAlan R Cohen, Ekkehard Glimm, John B Porter
International Journal of Hematology|October 14, 2011
Challenges of adherence and persistence with iron chelation therapyJohn B Porter, Michael Evangeli, Amal El-Beshlawy
American Journal of Hematology|November 24, 2021
Response to Cabantchik and Hershko commentary "Plasma nontransferrin bound iron-nontransferrin bound iron revisited: Implications for systemic iron overload and in iv iron supplementation"Maciej W Garbowski, John B Porter, Robert Hider
Hemoglobin|March 10, 2018
Psychological Factors Associated with Episodic Chelation Adherence in ThalassemiaJane Vosper, Michael Evangeli, John B Porter, et al.
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Hematology/Oncology Clinics of North America|July 28, 2014
The pathophysiology of transfusional iron overloadJohn B Porter, Maciej Garbowski
Hematology/Oncology Clinics of North America|February 21, 2018
Interaction of Transfusion and Iron Chelation in ThalassemiasJohn B Porter, Maciej W Garbowski
Best Practice & Research. Clinical Haematology|October 29, 2002
Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemiaJohn B Porter, Bernard A Davis
Advances in Experimental Medicine and Biology|February 8, 2003
Results of long term iron chelation treatment with deferoxamineBernard A Davis, John B Porter
Hematology/Oncology Clinics of North America|November 16, 2010
Iron overload in thalassemia and related conditions: therapeutic goals and assessment of response to chelation therapiesJohn B Porter, Farrukh T Shah
Hemoglobin|June 8, 2010
Which psychosocial factors are related to chelation adherence in thalassemia? A systematic reviewMichael Evangeli, Kulsoom Mughal, John B Porter
Blood|October 24, 2007
Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia majorAlan R Cohen, Ekkehard Glimm, John B Porter
International Journal of Hematology|October 14, 2011
Challenges of adherence and persistence with iron chelation therapyJohn B Porter, Michael Evangeli, Amal El-Beshlawy
American Journal of Hematology|November 24, 2021
Response to Cabantchik and Hershko commentary "Plasma nontransferrin bound iron-nontransferrin bound iron revisited: Implications for systemic iron overload and in iv iron supplementation"Maciej W Garbowski, John B Porter, Robert Hider
Hemoglobin|March 10, 2018
Psychological Factors Associated with Episodic Chelation Adherence in ThalassemiaJane Vosper, Michael Evangeli, John B Porter, et al.
Pageof 13